Influence of enalapril on experimental cyclosporin A nephrotoxicity

Pediatric Nephrology

Volumn 10, Issue 5, 1996, Pages 616-620

  Anarat, Ali ^a   Noyan, Aytul ^a,b   Gonlusen, Gulfiliz ^a   Duman, Naci ^a   Tuncer, Ilhan ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Cyclosporin A nephrotoxicity; Enalapril

Indexed keywords

CREATININE; CYCLOSPORIN A; ENALAPRIL;

ANIMAL EXPERIMENT; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; KIDNEY CALCIFICATION; KIDNEY TUBULE NECROSIS; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; UREA NITROGEN BLOOD LEVEL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CYCLOSPORINE; ENALAPRIL; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; RATS; RATS, WISTAR;

EID: 0029783423     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670050173     Document Type: Article

References (28)

1. Borel JF (1991) Mechanism of action of cyclosporin A and rationale for use in nephrotic syndrome. Clin Nephrol 35 [Suppl 1]: 23-30
2. Borel JF (1982) The history of cyclosporin A and its significance. In: White DJG (ed) Cyclosporin A: proceedings of an International Conference on Cyclosporin A. Elsevier, New York, pp 5-17
3. Danovitch GM (1992) Immunosuppressive medications and protocols for kidney transplantation. In: Danovitch GM (ed) Handbook of kidney transplantation. Little Brown, Boston/Toronto/ London, pp 67-103
4. Kim MS, Grupe WE (1992) The management of primary glomeruler disease. Alternatives to steroid therapy. In: Edelman CM (ed) Pediatric kidney disease, 2nd ed, vol 2. Little Brown, Boston, pp 1325-1353
5. Ponticelli S, Rivolta E (1988) Cyclosporine in nephrotic syndrome. Transplant Proc 20 [Suppl 4]:253-258
6. Bauer JH, Reams GP (1988) Renal protective effect of long term antihypertensive therapy with enalapril. Drugs 35 [Suppl 5]: 62-71
7. Fine LG (1988) Preventing the progression of human renal disease: have rational therapeutic principles emerged? Kidney Int 33: 116-128
8. Meyer TW, Anderson S, Rennke HG, Bienner BM (1987) Reversing glomerular hypertension stabilizes established glomerular injury. Kidney Int 31:752-759
9. Trachtman H, Gauthier B (1988) Effect of angiotensin-converting enzyme inhibitor therapy on proteinuria in children with renal disease. J Pediatr 112:295-298
10. Yoshida Y, Kawamura T, Ikoma M, Fogo A, Ichikawa I (1989) Effect of antihypertensive drugs on glomerular morphology. Kidney Int 36:626-635
11. Vea AM, Ruiz CG. Carrera M , Oliver JA, Richart J (1987) Effect of captopril in nephrotic-range proteinuria due to renovascular hypertension. Nephron 45:162-163
12. Abu-Romeh SH, El-Khatib D, Rashid A, Patel M, Osman N, Fayyad M, Scheikhani A, Higazi AZ (1992) Comparative effects of enalapril and nifedipine on renal hemodynamics in hypertensive renal allograft recipients. Clin Nephrol 37:183-188
13. Murray BM, Venuto RC, Kohli R, Conningham EE (1990) Enalapril-associated acute renal failure in renal transplants: possible role of cyclosporine. Am J Kidney Dis 16:66-69
14. Barros EJG, Boim MA, Ajzen H (1987) Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity. Kidney Int 32:19-32
15. Gillum DM, Truong L (1990) Effects of chronic volume expansion and enalapril on chronic cyclosporine nephropathy. Am J Physiol 258:F934-F939
16. Iacona A, Rosetti A, Filingeri V, Orsini D, Cesarini A, Cervelli V, Adorno D, Casciani CU (1991) Reduced nephrotoxicity and hepatoxicity in cyclosporin A therapy by enalapril and spironolactone in rats. Drugs Exp Clin Res 17:501-506
17. Murray BM, Paller MS, Ferris TF (1985) Effect of cyclosporine administration on renal hemodynamics in conscious rats. Kidney Int 28:767-774
18. Sumbuloglu K (1978) Saglik bilimlerinde arastirma teknikleri ve istatistik. Ankara Matis Yayinlari, Ankara, pp 58-68
19. Mihatsch MJ, Ryffel B, Hermle M, Brunner FP, Thiel G (1986) Morphology of cyclosporine nephrotoxicity in the rat. Clin Nephrol 5 [Suppl 1]:2-8
20. Mihatsch MJ, Thiel G, Basler V (1985) Morphological patterns in cyclosporine-treated renal transplant recipients. Transplant Proc 17:101-106
21. Ryffel B, Müller AM, Mihatsch MJ (1986) Experimental cyclosporine nephrotoxicity risk of concomitant chemotherapy. Clin Nephrol 25 [Suppl 1]: 121-125
22. Ryffel B, Siegl H, Petric R, Muller AM, HauserR, Mihatsch MJ (1986) Nephrotoxicity of cyclosporine in spontaneously hypertensive rats: effects on blood pressure and vascular lesions. Clin Nephrol 25 [Suppl 1]:193-198
23. 2 reduces nephrotoxicity and immunosuppression of cyclo-sporine in rats. Clin Nephrol 25 [Suppl 1]:95-99
24. Thiel G, Mihatsch MJ, Stahl RAK, Hermle M, Brunner FP (1986) Cyclosporin A nephrotoxicity in Goldblatt renovascular hypertension in rats. Clin Nephrol 25 [Suppl 1]: 199-204
25. Makowka L, Lopatin W, Gilas T, Falk J, Phillips MJ, Falk R (1986) Prevention of cyclosporine nephrotoxicity by synthetic prostaglandins. Clin Nephrol 25 [Suppl 1]:89-94
26. Verani R (1986) Cyclosporine nephrotoxicity in the Fischer rat. Clin Nephrol 25 [Suppl 1]:9-13
27. Kone BC, Racusen LC, Whelton A, Solez K (1986) Acute renal failure produced by combining cyclosporine and brief renal ischemia in the Munich wistar rat. Clin Nephrol 25 [Suppl 1]:171-174
28. Verpooten GA, Wybo I, Pattyn VM, Hendrix PG, Giuliano RA, Nouven EJ, Roels F, DeBroe ME (1986) Cyclosporine nephrotoxicity comparative cytochemical study of rat kidney and human allograft biopsies. Clin Nephrol 25 [Suppl 1]:18-22